Scholars Central

Conference abstractPublished 21 Jun 2017

Gram-negative bacterial phagelysates in anticancer therapy

Authors: K Gambashidze, A Sepashvili, P Khorava, T Azaladze, E Jaiani, B Lasareishvili, M Tediashvili

Tbilisi State Medical University, Georgia Eliava Institute, Georgia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Application of bacterial preparations for anticancer immunomodulation is one of the promising ways of immunotherapy. Our experimental studies have shown high immunogenicity and less toxicity of E. coli and P. aeruginosa phagelysates than bacterial thermolysates. We were aimed to investigate antitumor immunomodulatory and adjuvant potential of Gram-negative bacterial phagelysates in cancer-bearing mice. Phage lysate of E. coli-Shigella specific Un bacteriophage was obtained by propagation of EcUnphage in semisynthetic medium and tested for: Sterility, viable bacterial cell content (CFU/ml), phage particles (PFU/ml), optical density (600 nm), protein concentration (Bradford method), endotoxins (LAL tests) and safety. Treatment effects (E. coli-Un phage lysate vaccinations 0.25 ml/day; Cyclophosphan 800 mg/m2) in Ehrlich carcinoma-bearing C57BL/6J mice were estimated by: index of malignant growth (using semi-empirical mathematical model V=Vo{exp[(t-to)/T]-1}; cancer growth inhibition percent; CD3CD4, CD3CD8, CD25Foxp3, NK-cells, IL-12, IFN-Ã?³, TGF-Ã?² (using FACS-Array Bioanalyzer, BD-FACSCalibur, USA, WST-8 Cell-Proliferation Assay-Kit; ELISA according to manufactures protocol, R&D-systems). It was observed that E. coli-Un phage lysate vaccinations are well tolerated in mice. Chemotherapy inhibited cancer growth, but no increase in lifespan was observed. Phagelysates significantly increased efficacy of chemotherapy. Cancer development was inhibited by 80âÂ?Â?90%. In 13%-19% of mice with 250-450 mm3 cancers complete regression of tumors was detected. Increase in Tc-effectors and cytokines and decrease in T-regs indicate E. coli-Un phage lysate anticancer immunomodulatory and adjuvant potential. It can be concluded that bacterial phage lysates can be used as powerful adjuvant in anticancer therapy.

Subjects

Microbiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medical Microbiology & Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedical Microbiology & Diagnosis
  • SubjectMicrobiology
  • BylineArticles whose byline prints “K Gambashidze”
  • BylineArticles whose byline prints “A Sepashvili”
  • BylineArticles whose byline prints “P Khorava”
  • BylineArticles whose byline prints “T Azaladze”
  • BylineArticles whose byline prints “E Jaiani”
  • BylineArticles whose byline prints “B Lasareishvili”
  • BylineArticles whose byline prints “M Tediashvili”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels